Home
/
UNIVERSAL HEALTH SERVICES INC
/
Financials
/
Quarterly
UNIVERSAL HEALTH SERVICES INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that UNIVERSAL HEALTH SERVICES INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$4.50B
Nov 7, 2025
Q2
2025
Jun 30, 2025
$4.28B
Aug 8, 2025
Q1
2025
Mar 31, 2025
$4.10B
May 8, 2025
Q3
2025
Sep 30, 2024
$3.96B
Nov 7, 2025
Q2
2025
Jun 30, 2024
$3.91B
Aug 8, 2025
Q1
2025
Mar 31, 2024
$3.84B
May 8, 2025
Q3
2024
Sep 30, 2023
$3.56B
Nov 8, 2024
Q2
2024
Jun 30, 2023
$3.55B
Aug 8, 2024
Q1
2024
Mar 31, 2023
$3.47B
May 8, 2024
Q3
2023
Sep 30, 2022
$3.34B
Nov 8, 2023
Q2
2023
Jun 30, 2022
$3.32B
Aug 8, 2023
Q1
2023
Mar 31, 2022
$3.29B
May 8, 2023
Q3
2022
Sep 30, 2021
$3.16B
Nov 8, 2022
Q2
2022
Jun 30, 2021
$3.20B
Aug 8, 2022
Q1
2022
Mar 31, 2021
$3.01B
May 6, 2022
Q3
2021
Sep 30, 2020
$2.91B
Nov 8, 2021
Q2
2021
Jun 30, 2020
$2.73B
Aug 6, 2021
Q1
2021
Mar 31, 2020
$2.83B
May 7, 2021
Q3
2020
Sep 30, 2019
$2.82B
Nov 6, 2020
Q2
2020
Jun 30, 2019
$2.86B
Aug 7, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$2.69B
May 9, 2018
Q3
2017
Sep 30, 2017
$2.54B
Nov 8, 2017
Q2
2017
Jun 30, 2017
$2.61B
Aug 7, 2017
Q1
2018
Mar 31, 2017
$2.61B
May 9, 2018
Q3
2017
Sep 30, 2016
$2.41B
Nov 8, 2017
Q2
2017
Jun 30, 2016
$2.43B
Aug 7, 2017
Q1
2017
Mar 31, 2016
$2.45B
May 8, 2017
Q3
2016
Sep 30, 2015
$2.23B
Nov 8, 2016
Q2
2016
Jun 30, 2015
$2.28B
Aug 5, 2016
Q1
2016
Mar 31, 2015
$2.23B
May 6, 2016
Q3
2015
Sep 30, 2014
$2.04B
Nov 6, 2015
Q2
2015
Jun 30, 2014
$2.05B
Aug 7, 2015
Q1
2015
Mar 31, 2014
$1.94B
May 8, 2015
Q3
2014
Sep 30, 2013
$1.82B
Nov 7, 2014
Q2
2014
Jun 30, 2013
$1.83B
Aug 8, 2014
Q1
2014
Mar 31, 2013
$1.83B
May 7, 2014
Q3
2013
Sep 30, 2012
$1.68B
Nov 7, 2013
Q2
2013
Jun 30, 2012
$1.72B
Aug 8, 2013
Q1
2013
Mar 31, 2012
$1.79B
May 8, 2013
Q3
2012
Sep 30, 2011
$1.66B
Nov 8, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$372.96M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$353.22M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$316.68M
May 8, 2025
Q3
2025
Sep 30, 2024
$258.71M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$289.15M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$261.83M
May 8, 2025
Q3
2024
Sep 30, 2023
$166.99M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$171.31M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$163.12M
May 8, 2024
Q3
2023
Sep 30, 2022
$182.81M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$164.06M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$153.91M
May 8, 2023
Q3
2022
Sep 30, 2021
$218.35M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$325.02M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$209.09M
May 6, 2022
Q3
2021
Sep 30, 2020
$241.28M
Nov 8, 2021
Q2
2021
Jun 30, 2020
$251.93M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$142.04M
May 7, 2021
Q3
2020
Sep 30, 2019
$97.19M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$238.32M
Aug 7, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$521.69M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$500.27M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$454.83M
May 8, 2025
Q3
2025
Sep 30, 2024
$384.17M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$436.40M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$388.76M
May 8, 2025
Q3
2024
Sep 30, 2023
$285.36M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$280.13M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$278.70M
May 8, 2024
Q3
2023
Sep 30, 2022
$275.88M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$233.43M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$232.86M
May 8, 2023
Q3
2022
Sep 30, 2021
$314.81M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$438.97M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$295.67M
May 6, 2022
Q3
2021
Sep 30, 2020
$349.67M
Nov 8, 2021
Q2
2021
Jun 30, 2020
$358.03M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$236.69M
May 7, 2021
Q3
2020
Sep 30, 2019
$188.93M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$345.56M
Aug 7, 2020